GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » Total Liabilities

Qlife Holding AB (OSTO:QLIFE) Total Liabilities : kr58.50 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB Total Liabilities?

Qlife Holding AB's Total Liabilities for the quarter that ended in Sep. 2023 was kr58.50 Mil.

Qlife Holding AB's quarterly Total Liabilities declined from Mar. 2023 (kr115.58 Mil) to Jun. 2023 (kr56.41 Mil) but then increased from Jun. 2023 (kr56.41 Mil) to Sep. 2023 (kr58.50 Mil).

Qlife Holding AB's annual Total Liabilities declined from Dec. 2020 (kr38.33 Mil) to Dec. 2021 (kr31.51 Mil) but then increased from Dec. 2021 (kr31.51 Mil) to Dec. 2022 (kr101.50 Mil).


Qlife Holding AB Total Liabilities Historical Data

The historical data trend for Qlife Holding AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qlife Holding AB Total Liabilities Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Total Liabilities
14.12 38.33 31.51 101.50

Qlife Holding AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 122.23 101.50 115.58 56.41 58.50

Qlife Holding AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Qlife Holding AB's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=53.206+(48.293+0.0020000000000024
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=101.50

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=192.65-91.149
=101.50

Qlife Holding AB's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=53.651+(4.855+-0.002000000000006
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=58.50

Total Liabilities=Total Assets (Q: Sep. 2023 )-Total Equity (Q: Sep. 2023 )
=150.009-91.505
=58.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qlife Holding AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Qlife Holding AB (OSTO:QLIFE) Business Description

Traded in Other Exchanges
Address
Redaregatan 48, Helsingborg, SWE, SE-252 36
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines